Evaluation of the Impact of Tractions Vs. Placebo Tractions in Patients with Cervical Radiculopathy

Last updated: February 13, 2025
Sponsor: Centre Hospitalier Departemental Vendee
Overall Status: Active - Recruiting

Phase

N/A

Condition

Radiculopathy

Treatment

Intensive cervical traction protocol - placebo

Intensive cervical traction protocol

Clinical Study ID

NCT05952167
CHD 22_0054
  • Ages > 18
  • All Genders

Study Summary

Cervical radiculopathy is a common disease related to compression of the nerve roots of the spine (prevalence: 3.5/1000). Dysfunction and pain are the main repercussions and can lead to time off work and high costs in terms of treatment.

Second-line surgical treatments appear to be less effective and present risks of side effects. In the first instance, treatments are conservative and include medication but above all physiotherapy with manual therapy, muscle exercises and cervical traction. These cervical tractions performed by a physiotherapist require little equipment and are inexpensive compared with the surgical alternative. They involve stretching the cervical spine and soft tissues to open the intervertebral foramen and mobilise the facet joints.

Several authors have written summaries of their interest. Thoomes reports two studies and describes an absence of effect. In a meta-analysis, Romeo et al. added three more recent studies to the previous review and concluded that traction is effective, highlighting an "effect-dose" relationship. These recent results therefore seem to reverse the recommendations made barely two years later. Nevertheless, almost all the studies compared "manual therapy + exercises" with "manual therapy + exercises + cervical traction". Only Young et al. tested "manual therapy + exercises + cervical traction at an effective weight" compared to "manual therapy + exercises + cervical traction placebo at an ineffective weight". The study did not reveal any difference between the groups. However, several limitations appear in this study when comparing the protocol to studies that have shown efficacy. The main limitation is the low intensity (i.e. protocol with fewer sessions and longer duration). These clinical limitations may explain the lack of evidence of a positive outcome. Following on from a preliminary study evaluating an intensive cervical traction protocol over five days, and in order to discern the effect specific to the treatment (specific effect) and the effect independent of the nature of the treatment (contextual effect), the investigators wish to evaluate the impact of this intensive protocol by comparing it with placebo traction.

In current practice, treatment varies between establishments. The paucity of studies on cervical traction in radiculopathy has resulted in routine use being guided by habit rather than evidence. It remains a clinical question which raises a major issue requiring a robust experimental design. Ultimately, this study follows on from a preliminary study and is part of a comprehensive research project aimed at proposing new recommendations for the use of traction in patients suffering from cervical radiculopathy. The investigators are investigating the impact of an intensive traction vs. placebo traction protocol in patients with cervical radiculopathy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient over 18

  • Neck Disability Index ≥ 15/50

  • Presence of at least three of the four signs clinically validating the presence ofcervical radiculopathy (Wainner et al. 2003)

  • a) upper limb nerve tension test A (ULNT1a): positive,

  • b) amplitude of cervical rotation on the side concerned: < 60°,

  • c) positive cervical distraction test: relief

  • d) positive Spurling test: reproduction of symptoms.

  • Cervical radiculopathy diagnosed 3 to 12 months previously

  • Absence of cervical traction in the 5 years prior to inclusion

  • MRI or CT scan performed prior to hospitalisation in relation to current pathology

  • Patient able to understand the protocol and having given oral informed consent totake part in the research.

  • Patient affiliated to the social security system or entitled beneficiary.

Exclusion

Exclusion Criteria:

  • Patients with vertebral artery pathology at the time of inclusion

  • Patients with myelopathy, cervical cancer, cervical fracture, cervical dislocation,cervical spondylolisthesis, spinal infection, symptomatic cervical pain withoutradiculopathy and/or cervical surgery in the 2 years prior to inclusion.

  • Patient participating in another clinical research protocol with an impact on theobjectives of the research.

  • Patient who is pregnant, breastfeeding or able to procreate without effectivecontraception*.

  • Patient under guardianship, curatorship or deprived of liberty

  • Patient under activated future protection mandate

  • Patient under family habilitation

  • Patient under court protection.

Study Design

Total Participants: 206
Treatment Group(s): 2
Primary Treatment: Intensive cervical traction protocol - placebo
Phase:
Study Start date:
March 25, 2024
Estimated Completion Date:
September 25, 2027

Connect with a study center

  • CHD Vendée

    La Roche-sur-Yon,
    France

    Active - Recruiting

  • CH La Rochelle

    La Rochelle,
    France

    Active - Recruiting

  • CH Emile Roux

    Le Puy-en-Velay,
    France

    Active - Recruiting

  • CHU Limoges

    Limoges,
    France

    Active - Recruiting

  • CHU Nantes

    Nantes,
    France

    Active - Recruiting

  • APHP La Pitié Salpêtrière

    Paris,
    France

    Active - Recruiting

  • Chu Reims

    Reims,
    France

    Site Not Available

  • CHU Rouen

    Rouen,
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.